Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors.

Dawn L HershmanAlfred I NeugutAnna B MoseleyKathryn B ArnoldJulie R Gralow Norah L Henry Grace Clarke HillyerScott D RamseyJoseph M Unger

Published in: Journal of the National Cancer Institute (2022)

The presence of multiple baseline PRO-specified risk factors was statistically significantly associated with AI nonadherence. The use of these assessments can help identify patients for targeted interventions to improve adherence.

Keyphrases

patient reported outcomes
risk factors
end stage renal disease
newly diagnosed
chronic kidney disease
physical activity
prognostic factors
peritoneal dialysis
cancer therapy
type diabetes
metabolic syndrome
adipose tissue
insulin resistance
drug delivery
weight loss
glycemic control
deep learning